News & Press Releases

GlucoTrack® Maker Hires Chief Operating Officer

January 13th, 2016

GlucoTrack® Maker Hires Chief Operating Officer Ashdod, Israel, January 12, 2016 /PRNewswire/ — Integrity Applications, Inc. (OTCQB: IGAP), maker of GlucoTrack®, a non-invasive device for measuring glucose levels of people with Type 2 diabetes and pre-diabetics, announced that it has hired Eran Cohen as its Chief Operating Officer (COO). Mr. Cohen brings over 17 years of […]

Read More Download

GlucoTrack® Hires International Sales and Business Development Manager Will Assist in Building Global Sales Network

December 11th, 2015

GlucoTrack® Hires International Sales and Business Development Manager Will Assist in Building Global Sales Network Ashkelon, Israel, December 10, 2015 /PRNewswire/ — Integrity Applications, Inc. (OTCQB: IGAP), maker of GlucoTrack®, a non-invasive device for measuring glucose levels of people with Type 2 diabetes or at risk of developing diabetes, announced today that it has hired […]

Read More Download

GlucoTrack® Maker CEO Chairs and Presents at Annual World Congress of Diabetes – 2015

December 1st, 2015

GlucoTrack® Maker CEO Chairs and Presents at Annual World Congress of Diabetes – 2015 Gal Invited to Chair Session on Medical Devices in Diabetes Ashkelon, Israel, November 30, 2015 /PRNewswire/ — Integrity Applications, Inc. (OTCQB: IGAP), maker of GlucoTrack®, a non-invasive device for measuring glucose levels of people with Type 2 diabetes or at risk […]

Read More Download

GlucoTrack® Moves Forward with FDA Approval Process

October 30th, 2015

GlucoTrack® Moves Forward with FDA Approval Process Clinical Trial Initiation Planned for Early 2016 Ashkelon, Israel, October 29, 2015 /PRNewswire/ — Integrity Applications, Inc. (OTCQB: IGAP), maker of GlucoTrack®, a non-invasive device for measuring glucose levels of people with Type 2 diabetes or at risk of developing diabetes, announced today that on October 19, 2015, it […]

Read More

GlucoTrack® Maker Holds First International Distributor Conference

October 26th, 2015

GlucoTrack® Maker Holds First International Distributor Conference  Conference Promotes Sale Readiness in Europe ASHKELON, Israel, October 26, 2015 /PRNewswire/ — Integrity Applications, Inc. (OTCQB: IGAP), maker of GlucoTrack®, a non-invasive device for measuring glucose levels of people with Type 2 diabetes or at risk of developing diabetes, announced that it held its first Distributors Conference in […]

Read More Download

Integrity Applications Receives CE Mark Approval for Multiple Improvements to GlucoTrack® Model DF-F

August 31st, 2015

Integrity Applications Receives CE Mark Approval for Multiple Improvements to GlucoTrack® Model DF-F ASHKELON, Israel, August 31, 2015 /PRNewswire/ — Integrity Applications, Inc. (OTCQB: IGAP) (the “Company” or “Integrity”), has announced that it has received CE Mark approval from Dekra Certification B.V., its Notified Body in the European Union for improvements to the GlucoTrack model DF-F noninvasive glucose measurement […]

Read More Download

Integrity Applications Submits protocol to FDA (August 13 2015)

August 13th, 2015

Integrity Applications Submits Pre-Submission Documents for the GlucoTrack Model DF-F to U.S. FDA ASHKELON, Israel, August 13, 2015 /PRNewswire/ — Integrity Applications, Inc. (OTCQB: IGAP) (the “Company” or “Integrity”), developer of the GlucoTrack® model DF-F noninvasive glucose measurement device, has announced that on August 10th, 2015 it submitted pre-submission documents to the U.S. Food and Drug Administration (the “FDA”) […]

Read More Download

Integrity Applications Names Prof. Lutz Heinemann to Advisory Board

February 27th, 2015

Integrity Applications Names Prof. Lutz Heinemann to Advisory Board   Preeminent Expert In Diabetes Study Will Head New Advisory Board   ASHKELON, Israel, February 26, 2015 /PRNewswire/ — Integrity Applications, Inc. (OTCQB: IGAP) (the “Company” or “Integrity”), developer of the GlucoTrack® model DF-F, a noninvasive   device that tracks blood glucose levels, announced today that Dr. […]

Read More

Integrity Applications Signs Distribution Agreements for Its GlucoTrack® Model DF-F Glucose Monitoring Device in Hong-Kong and China

February 19th, 2015

Integrity Applications Signs Distribution Agreements for Its GlucoTrack® Model DF-F Glucose Monitoring Device in Hong-Kong and China   Noninvasive Blood Glucose Measurement Device For Diabetes   ASHKELON, Israel, February 17, 2015 /PRNewswire/ — Integrity Applications, Inc. (OTCQB: IGAP) (the “Company” or “Integrity”), developer of the GlucoTrack® model DF-F noninvasive blood glucose measurement device, has entered, […]

Read More

Integrity Applications, Inc. Announces Completion of Successful $8.5 Million Equity Financing

January 5th, 2015

Integrity Applications, Inc. Announces Completion of Successful $8.5 Million Equity Financing   ASHKELON, Israel, January 5, 2015 /PRNewswire/ — Integrity Applications, Inc. (OTCQB: IGAP) (the “Company” or “Integrity”), developer of the GlucoTrack® model DF-F noninvasive blood glucose measurement device, announced today that, on December 31, 2014, it raised an aggregate of $1,647,450 through the sale […]

Read More

Integrity Applications, Inc. Announces Equity Financing of $3.0 Million

September 5th, 2014

Integrity Applications, Inc. Announces Equity Financing of $3.0 Million ASHKELON, Israel, September 3, 2014 /PRNewswire/ — Integrity Applications, Inc. (OTCQB: IGAP) (“Integrity”), announced today that, on August 29, 2014, it raised an aggregate of $3,036,000 through the sale in a private placement transaction of 3,036 units (each a “Unit” and, collectively, the “Units”), at a […]

Read More Download

Integrity Applications, Inc. Enters into Manufacturing Agreement with Wistron Corp.

July 21st, 2014

Integrity Applications, Inc. Enters into Manufacturing Agreement with Wistron Corp.   ASHKELON, Israel – July 21, 2014 — Integrity Applications, Inc. (OTCQB: IGAP) (the “Company” or “Integrity”), developer of the GlucoTrack® model DF-F noninvasive blood glucose measurement device, announced today that it has entered, through its wholly-owned subsidiary, Integrity Applications Ltd., into a Manufacturing Agreement […]

Read More

Integrity Applications, Inc. announces first wholesale orders for its GlucoTrack® model DF-F glucose measurement device and the hiring of a Director of Marketing and Sales

July 21st, 2014

Integrity Applications, Inc. announces first wholesale orders for its GlucoTrack® model DF-F glucose measurement device and the hiring of a Director of Marketing and Sales   ASHKELON, Israel, July 2, 2014 /PRNewswire/ — Integrity Applications, Inc. (OTCQB: IGAP) (the “Company” or “Integrity”), developer of the GlucoTrack model DF-F noninvasive blood glucose measurement device, announced today […]

Read More

Integrity Applications Receives CE Mark Approval for Six-Month Calibration Validity of GlucoTrack® DF-F. Calibration Validity Now Corresponds to Lifespan of the Personal Ear Clip

March 22nd, 2014

Calibration Validity Now Corresponds to Lifespan of Personal Ear Clip ASHKELON, Israel, Mar 17, 2014 (BUSINESS WIRE) — Integrity Applications, Inc. (otcqb:IGAP), developer of the GlucoTrack® model DF-F noninvasive blood glucose measurement device, received CE Mark approval from Dekra Certification B.V., its Notified Body in the European Union, to extend its claim from a monthly recalibration […]

Read More

Integrity Applications Signs Two Additional Distribution Agreements for Its GlucoTrack® Model DF-F Glucose Monitoring Device

March 22nd, 2014

Integrity Applications Signs Two Additional Distribution Agreements for Its GlucoTrack® Model DF-F Glucose Monitoring Device GlucoTrack® Will Be Available in the Philippines and Chile  ASHKELON, Israel – March 20, 2014 — Integrity Applications, Inc. (OTCQB: IGAP), developer of the GlucoTrack® model DF-F noninvasive blood glucose measurement device, has entered, through its wholly-owned subsidiary, Integrity Applications […]

Read More

Integrity Applications Receives CE Mark Approval for Six-Month Calibration Validity of GlucoTrack® DF-F

March 19th, 2014

Integrity Applications Receives CE Mark Approval for Six-Month Calibration Validity of GlucoTrack® DF-F   Calibration Validity Now Corresponds to Lifespan of Personal Ear Clip   ASHKELON, Israel – March 17, 2014 — Integrity Applications, Inc. (OTCQB: IGAP), developer of the GlucoTrack® model DF-F noninvasive blood glucose measurement device, received CE Mark approval from Dekra Certification […]

Read More Download

Integrity Applications Signs Third Distribution Agreement for GlucoTrack® Model DF-F Glucose Monitoring Device

January 29th, 2014

Integrity Applications Signs Third Distribution Agreement for GlucoTrack® Model DF-F Glucose Monitoring Device Distributor Felkasta JSC Expected to Begin Sales by Q2 2014 in Lithuania, Latvia and Estonia and 2015 in Belarus ASHKELON, Israel Integrity Applications, Inc. (IGAP), developer of the GlucoTrack® model DF-F noninvasive blood glucose measurement device, has entered, through its subsidiary company, Integrity […]

Read More

Integrity Applications Signs Additional Distribution Agreement for GlucoTrack® Model DF-F Glucose Monitoring Device

January 15th, 2014

Integrity Applications Signs Additional Distribution Agreement for GlucoTrack® Model DF-F Glucose Monitoring Device Turkish Distributor Kocak Medical & Laboratory Technology Expected to Begin Sales by End of Second Quarter 2014 January 14, 2014 ASHKELON, ISRAEL — Integrity Applications, Inc. (OTCQB: IGAP), developer of the GlucoTrack®model DF-F non-invasive blood glucose measurement device, has entered into a distribution […]

Read More

Integrity Applications Signs Distribution Agreement for GlucoTrack® Model DF-F Glucose Monitoring Device

January 15th, 2014

Integrity Applications Signs Distribution Agreement for GlucoTrack® Model DF-F Glucose Monitoring Device Integrity Applications, Inc.January 13, 2014 7:00 AM ASHKELON, Israel–(BUSINESS WIRE)– Integrity Applications, Inc. (IGAP), developer of the GlucoTrack® model DF-F non-invasive blood glucose measurement device, has entered into a distribution agreement appointing Ultramedix Australasia Pty Ltd., with their depth of specialist clinical expertise and […]

Read More

Integrity Applications to Present at the Sidoti & Company Semi-Annual Micro-Cap Conference in New York City on January 13, 2014

January 8th, 2014

http://www.businesswire.com/news/home/20140108005181/en/Integrity-Applications-Present-Sidoti-Company-Semi-Annual-Micro-Cap#.Us1MOhYQSlI Integrity Applications to Present at the Sidoti & Company Semi-Annual Micro-Cap Conference in New York City on January 13, 2014 January 08, 2014 08:00 AM Eastern Standard Time Sidoti & Company Semi-Annual Microcap Conference ASHKELON, Israel–(BUSINESS WIRE)–Integrity Applications, Inc. (OTCQB:IGAP), developer of the GlucoTrack® model DF-F non-invasive blood glucose measurement device, today announced that Avner […]

Read More

Sign up to our newsletter
To receive occasional news updates

LinkedIn Facebook Twitter